Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

LONDON BROKER RATINGS: Goldman and UBS cut Legal & General to 'sell'

11th Aug 2026 09:37

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:

----------

FTSE 100

----------

UBS cuts M&G to 'sell' (neutral) - price target 330 (300) pence

----------

Goldman Sachs cuts Legal & General to 'sell' (neutral) - price target 257 pence

----------

UBS cuts Legal & General to 'sell' (neutral) - price target 280 (260) pence

----------

RBC raises Legal & General price target to 270 (255) pence - 'underperform'

----------

Jefferies raises Admiral price target to 4,400 (3,770) pence - 'buy'

----------

Kepler Cheuvreux starts ICG with 'buy' - price target 55 pence

----------

Kepler Cheuvreux raises Lloyds Banking price target to 133 (127) pence - 'buy'

----------

JPMorgan raises Spirax price target to 8,600 (7,800) pence - 'neutral'

----------

Jefferies raises Unilever price target to 3,900 (3,800) pence - 'underperform'

----------

Deutsche Bank Research raises BAE Systems price target to 2,325 (2,140) pence - 'hold'

----------

RBC starts BAE Systems with 'sector perform' - price target 2,200 pence

----------

Barclays starts Babcock International with 'overweight' - price target 1,380 pence

----------

LBBW raises Shell price target to 3,600 (3,450) pence - 'buy'

----------

RBC raises Haleon price target to 390 (370) pence - 'sector perform'

----------

RBC raises British American Tobacco price target to 3,800 (3,600) pence - 'up'

----------

FTSE 250

----------

Jefferies cuts Plus500 price target to 4,720 (5,350) pence - 'buy'

----------

Deutsche Bank Research raises IntegraFin price target to 490 (475) pence - 'buy'

----------

Deutsche Bank Research cuts Shawbrook price target to 600 (610) pence - 'buy'

----------

Deutsche Bank Research raises Derwent London price target to 2,000 (1,850) pence - 'hold'

----------

Berenberg raises Hikma Pharmaceuticals target to 2,100 (1,800) pence - 'buy'

----------

Barclays raises Qinetiq price target to 620 (540) pence - 'overweight'

----------

JPMorgan raises Genuit price target to 450 (440) pence - 'overweight'

----------

SMALL CAP

----------

RBC cuts Marshalls group price target to 165 (170) pence - 'sector perform'

----------

Comments and questions to [email protected]

Copyright 2026 Alliance News Ltd. All Rights Reserved.


Related Shares:

M&GLegal & GeneralAdmiralIcg PlcLloydsSpirax-SarcoUnileverBAE SystemsBabcockShellHaleonBritish American TobaccoPlus500IntegraFin HoldingsShawbrook GroupDerwent LondonHikma PharmaceuticalsQinetiqGenuit GroupMarshalls
FTSE 100 Latest
Value10,869.65
Change7.15